Document and Entity Information Document Type Document Quarterly Report Document Transition Report Document Period End Date Securities Act File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Central Index Key Amendment Flag Condensed Consolidated Balance Sheets Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Short-Term Investments Short-term investments Accounts Receivable, after Allowance for Credit Loss, Current Accounts receivable, net Inventory, Net Inventory Total Inventory Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Operating Lease, Right-of-Use Asset Right-of-use asset Finite-Lived Intangible Assets, Net Total Intangible assets, net Restricted Cash Restricted cash Other Long-Term Investments Other long-term assets Assets Total assets Liabilities and Equity [Abstract] Liabilities, Convertible Preferred Stock and Stockholders' equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses and other current liabilities Accrued expenses and other current liabilities Other Liabilities, Current Other current liability - LG Chem Operating Lease, Liability, Current Lease liability Deferred Revenue, Current Deferred revenue Long-Term Debt, Current Maturities Deferred royalty obligation, current Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Long-term liabilities: Long-Term Debt, Excluding Current Maturities Deferred royalty obligation Operating Lease, Liability, Noncurrent Lease liability, non-current Derivative Liability Derivative liability Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 14) Temporary Equity, Carrying Amount, Attributable to Parent Ending balance Beginning balance Series A convertible preferred stock, $0.001 par value: 150,000 shares authorized; 150,000 and 150,000 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively. Liquidation preference of $150,000 as of June 30, 2025. Carrying value of convertible preferred stock Equity, Attributable to Parent [Abstract] Stockholders' equity: Common Stock, Value, Issued Common stock, $0.001 par value: 120,000,000 shares authorized; 63,913,185 and 62,390,654 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively Fair value of common stock issued Additional Paid in Capital Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive (loss) Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Equity, Attributable to Parent Ending balance Beginning balance Total stockholders' equity Liabilities and Equity Total liabilities, convertible preferred stock and stockholders' equity Statement [Table] Statement Class of Stock [Axis] Class of Stock [Domain] Represents the information pertaining to convertible preferred stock. SeriesA Convertible Preferred Stock [Member] Common stock reserved for the conversion of Series A convertible preferred stock Series A Convertible Preferred Stock Statement [Line Items] Statement Temporary Equity, Par or Stated Value Per Share Convertible preferred stock, par value Temporary equity, par value per share Temporary Equity, Shares Authorized Convertible preferred stock, authorized Temporary Equity, Shares Issued Issuance of Series A Preferred Stock, net of $2,250 of issuance costs (in shares) Convertible preferred stock, issued Temporary Equity, Shares Outstanding Ending balance (in shares) Beginning balance (in shares) Convertible preferred stock, outstanding Temporary Equity, Liquidation Preference Liquidation preference Preferred Stock, Par or Stated Value Per Share Preferred stock par value per share Preferred Stock, Shares Authorized Preferred stock, authorized Preferred Stock, Shares Issued Preferred stock, issued Preferred Stock, Shares Outstanding Preferred stock, outstanding Common Stock, Par or Stated Value Per Share Common stock, par value per share Common Stock, Shares Authorized Common stock, authorized Common Stock, Shares, Issued Common stock, issued Common Stock, Shares, Outstanding Common stock, outstanding Condensed Consolidated Statements of Operations and Comprehensive Loss Product and Service [Axis] Product and Service [Domain] Product [Member] Product revenue, net License [Member] License revenue Revenue from Contract with Customer, Excluding Assessed Tax Total revenues Total revenue, net Costs and Expenses [Abstract] Costs and expenses: Cost of Goods and Services Sold Cost of sales Research and Development Expense Research and development Selling, General and Administrative Expense Selling, general, and administrative Costs and Expenses Total costs and expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income (expense): Other Nonoperating Income (Expense) Other income (expense), net Derivative, Gain (Loss) on Derivative, Net Gain on settlement of forward contract Gain on settlement of forward contract Interest Expense, Nonoperating Interest expense Investment Income, Net Interest income Nonoperating Income (Expense) Total other (expense), net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes Income Tax Expense (Benefit) Provision for income taxes Net loss Net loss The amount of convertible preferred stock dividends that is an adjustment to net income apportioned to common stockholders. Convertible Preferred Stock Dividends Accrued dividends on convertible preferred stock Net Income (Loss) Available to Common Stockholders, Basic Net loss attributable to common stockholders Net loss attributable to common stockholders Earnings Per Share, Basic Net loss per share attributable to common stockholders, basic (in dollars per share) Earnings Per Share, Diluted Net loss per share attributable to common stockholders, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted-average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average common shares outstanding, diluted (in shares) Other Comprehensive Income (Loss), Net of Tax [Abstract] Other comprehensive loss: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation adjustment OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Unrealized (loss), net on marketable securities Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Condensed Consolidated Statements of Convertible Preferred Stock & Stockholders' Equity Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common stock Common Stock Additional Paid-in Capital [Member] Additional Paid-In Capital AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) Retained Earnings [Member] Accumulated Deficit Sale of Stock [Axis] Sale of Stock [Domain] Sales in an at-the-market" offerings. At The Market Offerings [Member] At-the-market offering Temporary Equity [Abstract] Temporary Equity Temporary Equity, Stock Issued During Period, Value, New Issues Issuance of Series A Preferred Stock, net of $2,250 of issuance costs Temporary Equity, Accretion of Dividends Accretion of preferred stock dividends Accretion of preferred stock dividends Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity Shares, Outstanding Ending balance (in shares) Beginning balance (in shares) APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock compensation expense Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common stock in connection with ESPP Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock in connection with ESPP (in shares) The value of share options and vesting of stock units exercised during the current period. Stock Issued During Period Value Stock Options And Restricted Stock Units Vesting Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units Number of share options and vesting of stock units exercised during the current period. Stock Issued During Period Shares Stock Options And Restricted Stock Units Vesting Issuance of common stock in connection with exercise of stock options and vesting of restricted stock units (in shares) Stock Issued During Period, Value, New Issues Issuance of common stock upon completion of public offering, net of offering costs Issuance of stock Stock Issued During Period, Shares, New Issues Issuance of common stock upon completion of public offering, net of offering costs (in shares) Issuance of stock (in shares) Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings Accretion of preferred stock dividends Equity impact of the value of new stock issued during the period from license agreement. Stock Issued During Period, Value, New Issues License Agreement Issuance of common stock as consideration for LGC license Number of new stock issued during the period from license agreement. Stock Issued During Period, Shares, New Issues License Agreement Issuance of common stock as consideration for LGC license (in shares) Amount of unrealized and realized gain (loss) on investment in marketable securities. Maketable Securities, Gain (Loss), Total Unrealized loss on marketable securities Amount of issuance cost incurred on issuance of temporary equity. Temporary Equity, Stock Issuance Cost Issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Net offering costs Condensed Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Operating activities Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense The aggregate expense charged against earnings for both property and equipment including intangible assets. DepreciationDepletionAndAmortizationPropertyAndEquipmentIncludingIntangibleAssets Depreciation and amortization Amount of Non-cash interest expense. Non cash Interest Expense Non-cash interest expense Amount of non-cash accretion & amortization of short-term investments. Non cash Accretion And Amortization Of Short Term Investments Non-cash accretion & amortization of short-term investments Amount of deferred rent expense (reversal of expense). Deferred Rent Expense Non-cash rent expense Increase (Decrease) in Derivative Liabilities Change in fair value of embedded derivative liability The amount of acquired were In-Process Research and Development assets classified as operating activities. Acquired In-Process Research and Development Assets Classified as Operating Activities Acquired IPR&D assets classified as investing activities Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Foreign currency (gain) loss Increase (Decrease) in Operating Assets [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Deferred Revenue Deferred revenue Increase (Decrease) in Other Noncurrent Assets Other long-term assets, net Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable, accrued expenses and other liabilities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Investing activities Payments to Acquire Short-Term Investments Purchases of short-term investments Proceeds from Maturities, Prepayments and Calls of Short-Term Investments Maturities of short-term investments Payments to Acquire Intangible Assets Acquisition of IPR&D assets Net Cash Provided by (Used in) Investing Activities Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Financing activities Repayments of Long-Term Debt Repayment of deferred royalty obligation Proceeds from Stock Options Exercised Proceeds from the exercise of stock options Proceeds from Stock Plans Proceeds from issuance of common stock from ESPP Proceeds from Issuance of Redeemable Convertible Preferred Stock Proceeds from Series A Preferred Stock, net of issuance costs Proceeds from Derivative Instrument, Financing Activities Gain on settlement of forward contract Proceeds from Issuance of Common Stock Net proceeds from issuance of common stock Proceeds from ATM equity offering Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Effect of exchange rates on cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Cash, cash equivalents and restricted cash at end of period Cash, cash equivalents and restricted cash at beginning of period Noncash Investing and Financing Items [Abstract] Supplemental disclosure of non-cash investing and financing activities: Noncash or Part Noncash Acquisition, Value of Liabilities Assumed Non-current liability issued in exchange for the acquisition of IPR&D The value of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Shares Issued Issuance of common stock in exchange for IPR&D Nature of Business Nature of Operations [Text Block] Nature of Business Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Asset Acquisitions Asset Acquisition [Text Block] Asset Acquisitions Inventory Inventory Disclosure [Text Block] Inventory Accrued Expenses and Other Current Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses and Other Current Liabilities Fair Value of Financial Assets and Liabilities Fair Value Disclosures [Text Block] Fair Value of Financial Assets and Liabilities Intangible Assets, Net Intangible Assets Disclosure [Text Block] Intangible Assets, Net Income Taxes Income Tax Disclosure [Text Block] Income Taxes Series A Convertible Preferred Stock The entire disclosure is for Temporary Equity. Temporary Equity [Text Block] Series A Convertible Preferred Stock Common Stock. Equity [Text Block] Common Stock Related-Party Transactions Related Party Transactions Disclosure [Text Block] Related-Party Transactions No Definition. Significant Agreements Collaborative Arrangement Disclosure [Text Block] Significant Agreements Long-Term Obligations Debt Disclosure [Text Block] Long-Term Obligations Commitments and Contingencies. Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Segment and Geographic Information Segment Reporting Disclosure [Text Block] Segment and Geographic Information Subsequent Events Subsequent Events [Text Block] Subsequent Events Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Basis of Presentation Use of Estimates, Policy [Policy Text Block] Use of Estimates Consolidation, Policy [Policy Text Block] Principles of Consolidation Segment Reporting, Policy [Policy Text Block] Segment and Geographic Information Off-Balance-Sheet Credit Exposure, Policy [Policy Text Block] Off-Balance Sheet Risk and Concentrations of Credit Risk Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Investment, Policy [Policy Text Block] Short-Term Investments Accounts Receivable [Policy Text Block] Accounts Receivable, net Revenue [Policy Text Block] Revenue Recognition Disclosure of accounting policy for License Agreements. License Agreements, Accounting Policy [Policy Text Block] License Agreements Disclosure of accounting policy for Deferred Royalty Obligation. Deferred Royalty Obligation, Accounting Policy [Policy Text Block] Deferred Royalty Obligation Inventory, Policy [Policy Text Block] Inventory Disclosure of accounting policy for cost of product sales. Cost Of Product Sales [Policy Text Block] Cost of Product Sales Intangible Assets, Finite-Lived, Policy [Policy Text Block] Intangible Assets, Net Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets and assessing and recognizing impairments of its property, plant and equipment. Impairment or Disposal of Long-Lived Assets And Property, Plant and Equipment [Policy Text Block] Impairment of Long-Lived Assets Disclosure of accounting policy for acquired finite lived intangibles Acquired Finite Lived Intangibles [Policy Text Block] Acquired IPR&D and Milestone Expense Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Translation Fair Value Measurement, Policy [Policy Text Block] Fair Value Measurements Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share Subsequent Events, Policy [Policy Text Block] Subsequent Events New Accounting Pronouncements, Policy [Policy Text Block] Application of New or Revised Accounting Standards Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block] Schedule of potential common shares, presented based on amounts outstanding at each period end, excluded from computation of diluted net loss per share attributable to common stockholders Schedule of Inventory, Current [Table Text Block] Schedule of inventory Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of financial assets and liabilities measured at fair value on a recurring basis Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of changes in the estimated fair value of Level 3 securities Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Schedule of marketable securities Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of finite-lived intangible assets Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Schedule of amortization expense Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of segment profit or loss, including significant segment expenses Revenue from External Customers by Geographic Areas [Table Text Block] Schedule of revenue by geographic area Cash, Cash Equivalents, and Short-Term Investments Carrying amount of cash and cash equivalents and short term investments Inventory, Current [Table] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Customer Concentration Risk [Member] Customer concentration risk Customer [Axis] Customer [Domain] Represents information pertaining to customer one. Customer One [Member] Customer one Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Revenue Benchmark [Member] Revenue benchmark Accounts Receivable [Member] Accounts receivable Inventory [Line Items] Summary of Significant Accounting Policies Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract] Segment and Geographic Information Number of Operating Segments Number of operating segments Number of Reportable Segments Number of reporting segments No definition available. Off Balance Sheet Risk and Concentrations of Credit Risk [Abstract] Off Balance Sheet Risk and Concentrations of Credit Risk The number of federally insured financial institutions. Number of Federally Insured Financial Institutions Number of federally insured financial institutions Concentration Risk, Percentage Concentration risk percentage Revenue Recognition [Abstract] Revenue Recognition The number of pharmacies to which the company sells product. Number of Pharmacies Product Sold Number of pharmacies to which the company sells product Tangible Asset Impairment Charges [Abstract] Impairment of Long-Lived Assets Tangible Asset Impairment Charges Tangible asset impairment charges No definition available. Patent Costs [Abstract] Patent Costs Labor and Related Expense Employment cost Global headcount expense Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Restricted Stock Units (RSUs) [Member] Restricted stock units Performance Shares [Member] Performance stock units Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Shares excluded from the computation of diluted net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potential common shares Asset Acquisition [Table] Counterparty Name [Axis] Counterparty Name [Domain] Represents the information pertaining to the LG Chem Ltd. L G Chem Ltd [Member] LG Chem, LTD. Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Research and Development Expense [Member] Research and development Selling, General and Administrative Expenses [Member] Selling, general and administrative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Represents the information pertaining to license agreement and share issuance agreement. License Agreement And Share Issuance Agreement [Member] License agreement and share issuance agreement Asset Acquisition [Line Items] Asset Acquisitions Business Combination, Consideration Transferred Purchase consideration Payments to Acquire Businesses, Net of Cash Acquired Aggregate consideration at closing Threshold period for calculating weighted average price per share. Threshold Period For Calculating Weighted Average Closing Price Per Share Period for calculating weighted average closing price per share The amount of upfront consideration received in cash in license agreement. License Agreement Consideration Payment Received In Cash License agreement consideration payment received in cash The lock up period for subsequent cash payment in the agreement. Lock Up Period For Subsequent Cash Payment Lock up period for subsequent cash payment Accounts Payable, Fair Value Disclosure License fee payable Amount of license fee payable. License Fee Payable Carrying value of license fee payable Business Combination, Acquisition Related Costs Acquisition related costs Represent the amount of aggregate payment upon achievement of development and commercial milestones. Aggregate Payment Upon Achievement Of Development And Commercial Milestones Aggregate payment upon achievement of development and commercial milestones Inventory, Raw Materials and Supplies, Gross Raw Materials Inventory, Work in Process, Gross WIP Inventory, Finished Goods, Gross Finished Goods Amount of expenses incurred but not yet paid related to research and development, due within one year or the normal operating cycle, if longer. Accrued Research and Development Costs Research and development costs Accrued Professional Fees, Current Professional fees Amount of expenses incurred but not yet paid related to payroll, due within one year or the normal operating cycle, if longer. Accrued Payroll Related Expense Current Payroll related Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Royalties, Current Royalties Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales allowances. Sales Allowances Accrued, Current Sales allowances Other Accrued Liabilities, Current Other Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Recurring [Member] Recurring Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 Fair Value, Inputs, Level 2 [Member] Level 2 Fair Value, Inputs, Level 3 [Member] Level 3 Financial Instrument [Axis] Financial Instruments [Domain] Money Market Funds [Member] Money market funds US Treasury Securities [Member] US treasury securities Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment. Includes commercial paper. Corporate Debt Securities And Commercial Paper [Member] Corporate debt securities and commercial paper Commercial Paper [Member] Commercial Paper Measurement Basis [Axis] Portion at Fair Value Measurement [Member] Estimate of Fair Value Measurement [Member] Estimated fair value Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value of Financial Assets and Liabilities Assets, Fair Value Disclosure [Abstract] Fair value of financial assets and liabilities Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Debt Securities, Available-for-Sale Marketable securities Fair Value Assets, Fair Value Disclosure Fair value of assets Derivative Asset Derivative asset Derivative Instrument [Axis] Derivative Contract [Domain] Embedded Derivative Financial Instruments [Member] Embedded Derivative Financial Instruments Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Roll forward of the fair value of financial liabilities and assets Fair value of financial instrument classified as a liability or asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Asset Value, Beginning Balance Ending aggregate estimated fair value of Level 3 liability (asset) Beginning aggregate estimated fair value of Level 3 liability (asset) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Change in fair value of embedded derivative Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Fair value of forward contract - Series A Convertible Preferred Stock Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Settlement of forward contract Debt Securities, Available-for-Sale, Amortized Cost Amortized Cost Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Intangible Asset, Finite-Lived [Table] Indefinite-Lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Information pertaining to capitalized milestones. Capitalized Milestones [Member] Capitalized Milestones Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets Finite-Lived Intangible Asset, Useful Life Estimated life (years) Finite-Lived Intangible Assets, Gross Cost Finite-Lived Intangible Assets, Accumulated Amortization Accumulated Amortization Cost of Sales [Member] Cost of sales Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Definite-lived intangible assets Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four 2029 Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Finite-Lived Intangible Asset, Expected Amortization, after Year Four Thereafter Amortization of Intangible Assets Amortization expense Temporary Equity, by Class of Stock [Table] Liability Class [Axis] Fair Value by Liability Class [Domain] Forward Contracts [Member] Forward Contracts Scenario [Axis] Scenario [Domain] Represents the information of one holder pertaining to Series A convertible preferred stock. One Holder Of Series A Convertible Preferred Stock [Member] One holder of Series A convertible preferred stock Represents the information of a second holder pertaining to Series A convertible preferred stock. A Second Holder Of Series A Convertible Preferred Stock [Member] Separate holder of Series A convertible preferred stock Temporary Equity [Line Items] Series A Convertible Preferred Stock Number of new stock classified as temporary equity issued during the period. Temporary Equity, Stock Issued During Period, Shares, New Issues Convertible Preferred Stock Issuance and sale of shares of a new series Value of new stock classified as temporary equity . Temporary Equity, Aggregate Purchase Price Aggregate purchase price Per share or per unit amount of temporary equity issued. Temporary Equity, Shares Issued, Price Per share Per share or per unit amount of temporary equity issued Temporary Equity, Contract Terms Term to maturity per share or per unit amount of temporary equity issued Fair value of the entity's temporary equity. Temporary Equity, Fair Value Disclosure Fair value of convertible preferred stock Share Price Price per share Represents the multiplier factor to liquidation preference per share, in calculating the payment to be received in case liquidation. Temporary Equity, Liquidation Preference, Multiplier Factor Multiplier factor to liquidation preference per share Temporary Equity, Liquidation Preference Per Share Initial Liquidation Preference of per share The percentage rate used to calculate dividend payments on temporary equity. Temporary Equity, Dividend Rate, Percentage Annual rate of convertible preferred stock Preferred Stock, Convertible, Conversion Price Conversion price Convertible Preferred Stock, Shares Issued upon Conversion Shares issued upon conversion Percentage ownership after conversion of preferred stock. Percentage of Ownership after Conversion Percentage ownership after conversion of preferred stock The limited the voting rights of the Convertible Preferred Stock to the shares of the Company's common stock. Limited Voting Rights, Shares Limited voting rights of convertible preferred stock to common stock shares Step up interest rate. Step Up Interest Rate, Percentage Step up interest rate Stock, Class of Stock [Table] Asset Acquisition [Axis] Asset Acquisition [Domain] Represents the information pertaining to the rights of compound LB54640. Rights of Compound L B 54640 [Member] Rights of compound L B 54640 Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Plan Name [Axis] Plan Name [Domain] Represents the information pertaining to stock options, restricted stock units, and performance stock units in aggregate. Stock Options Restricted Stock Units Performance Stock Units In Aggregate [Member] Options, restricted stock units, and performance stock units in aggregate Represents the 2017 Equity Incentive Plan which provides for the grants of shares of common stock, restricted stock or incentive stock options and/or non qualified stock options to purchase our common stock to selected employees, directors, officers, agents, consultants, attorneys, vendors, and advisors. Stock Incentive Plan 2017 [Member] 2017 Equity Incentive Plan Represents the information pertaining to 2017 employee stock purchase plan (ESPP). Two Thousand Seventeen Employee Stock Purchase Plan [Member] 2017 Employee Stock Purchase Plan Information regarding the 2022 Employment Inducement Plan. Employment Inducement Plan 2022 [Member] 2022 Employment Inducement Plan Represents the information pertaining to both the 2017 employee stock purchase plan (ESPP) and the 2022 employment inducement plan in aggregate. Two Thousand Seventeen Employee And Employment Inducement Plan 2022Stock Purchase Plans In Aggregate [Member] 2017 equity incentive plan and the 2022 employment inducement plan in aggregate Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent events Class of Stock [Line Items] Stock Common Stock, Capital Shares Reserved for Future Issuance Common stock reserved for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Shares available for future grant The estimated number of shares to be issued upon conversion of convertible preferred stock. Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Estimated Estimated number of shares to be issued upon conversion of convertible preferred stock Sale of Stock, Consideration Received on Transaction Aggregate proceeds Collaborative Arrangement and Arrangement Other than Collaborative [Table] Represents information pertaining to termination agreement. Termination Agreement [Member] Termination Agreement Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Significant Agreements Amount of upfront fees received pursuant to agreement repaid back to the other party upon termination of agreement. Repayment Of Upfront Fees On Termination Amount of upfront fees received Amount of additional consideration to be paid for share repurchase. Additional Consideration For Share Repurchase Amount of additional consideration Amount of previously recognized license revenue reversed upon termination of contract. Reversal Of License Revenue Recognized on Termination Of Contract Amount of previously recognized license revenue Amount of net reduction in license revenue upon termination of contract. Net Reduction In License Revenue Upon Termination Of Contract Amount of net reduction in license revenue Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument, Name [Domain] Represents information pertaining to revenue interest financing agreement. Revenue Interest Financing Agreement [Member] Revenue Interest Financing Agreement Represents information pertaining to royalty interest financing agreement. Royalty Interest Financing Agreement [Member] Royalty Interest Financing Agreement Minimum [Member] Minimum Represents information pertaining to annual net revenues up to $125 million. Annual Net Revenues Up To 125 Million [Member] Annual net revenues up to 125 million Represents information pertaining to annual net revenues between $125 million and $300 million. Annual Net Revenues Between 125 Million And 300 Million [Member] Annual net revenues between 125 million and 300 million Represents information pertaining to annual net revenues exceeding $300 million. Annual Net Revenues Exceeding 300 Million [Member] Annual net revenues exceeding 300 million Represents information pertaining to cumulative minimum payments threshold date March 31, 2027. Cumulative Minimum Payments Funding Threshold Date March 31 2027 [Member] March 31, 2027 Represents information pertaining to cumulative minimum payments threshold date March 31, 2029. Cumulative Minimum Payments Funding Threshold Date March 31 2029 [Member] March 31, 2029 Debt Instrument [Line Items] Long-Term Obligations Debt Instrument, Face Amount Aggregate investment amount The cash inflow from the royalty financing agreement, net of issuance costs. Proceeds From Royalty Financing Agreement Remaining Investment Amount The percent of royalty interest payment on annual net revenues, payable to investors. Percent of Royalty Interest Payment on Annual Net Revenues Royalty interest (as a percent) The amount of threshold annual net sales for calculating revenue interest. Threshold Annual Net Revenues for Royalty Interest Threshold annual net revenues The threshold percentage of cumulative minimum payments to be funded to investors, the failure of which would require cash payment immediately following each applicable date to the Investors sufficient to gross the Investors up to such minimum amounts after giving full consideration of the cumulative amounts paid by to the Investors through each date, referred to as the Under Performance Payment. Threshold Percent of Cumulative Minimum Payments Funding to Investors Threshold cumulative minimum payments (as a percent) Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security Repayment of debt Proceeds from (Repayments of) Long-Term Debt and Capital Securities Cumulative repayment of debt The percent of total revenue interests payable cap as a percent of investment amount. Revenue Interests Payable Cap as Percent of Investment Amount Revenue interest cap (as a percent) The period within which the hard cap of initial investment amount to be received by investors. Revenue Interest Payment, Period from Initial Closing Revenue interest payment period Embedded Derivative, Fair Value of Embedded Derivative, Net Fair value of embedded derivative asset (liability) Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Remeasurement of the embedded derivative liability Deferred Revenue, Noncurrent Deferred royalty obligation Debt Instrument, Interest Rate, Effective Percentage Effective interest rate Debt Issuance Costs, Net Debt issuance costs Duration of time milestone payments are not expected to be paid to third parties, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but not limited to, weeks in a year or quarter. Duration Milestone Payments Not Expecting To Be Paid Duration of time milestone payments are not expected to be paid to third parties Number of business segments reported by the entity. Number of Business Segments Number of business segments Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] Represents information pertaining to single reportable segment. Single Reportable Segment [Member] Single reportable segment Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] UNITED STATES US Non-US [Member] International Segment Reporting Information [Line Items] Segment and Geographic Information Amount of preclinical, clinical and development expenses of the company. Preclinical, Clinical And Development Expense Preclinical, clinical and development expense Amount of expenses attributable to commercialization of products, its marketing activities and the expenses for its medical affairs. Commercial And Medical Expenses Commercial & medical affairs General and Administrative Expense Corporate, general & administrative Other General Expense Other segment expenses Segment Reporting, Other Segment Item, Amount Other (income) expense, net Interest Income (Expense), Nonoperating Interest (income) expense, net Amount of segment current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Segment Income Tax Expense (Benefit) Income taxes Subsequent Event [Table] Represents information pertaining to follow on offering. Follow On Offering [Member] Follow-on offering Over-Allotment Option [Member] Underwriter option to purchase Subsequent Event [Line Items] Subsequent events The cash outflow for additional consideration to acquire assets. Payment For Additional Consideration On Asset Acquisition Final consideration payment The number of shares to be issued in an offering. Number Of Shares To Be Issued Number of shares issued Shares Issued, Price Per Share Offering price The number of days within which the underwriter has to exercise the option. Number Of Days To Exercise Underwriting Option Option to exercise